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Abstract Over the last several years, carbapenemase-producing
Enterobacteriaceae (CPE) have been increasingly detected not
only among patients in acute care hospitals, but also in long-
term care facilities. In this point prevalence survey, residents
from three nursing homes and patients in one rehabilitation
center were screened for asymptomatic intestinal carriage of
CPE by rectal swabs. The first objective was to evaluate the
hypothesis of the establishment of a CPE reservoir in a
geriatric/chronic care population. Secondly, we evaluated
the comparative performances of different culture methods
(chromID® CARBA, chromID® OXA-48, MacConkey with
temocillin/meropenem, ertapenem enrichment broth) and a
commercial molecular assay (Check-Direct CPE). From the
257 included residents, only one had evidence for CPE car-
riage. From the rectal swabs of this resident, an OXA-48-
producing Klebsiella pneumoniae could be isolated and was
confirmed by a molecular assay both on the strain and on
the rectal swab. The specificity of the different culture
methods and Check-Direct CPE was at least 97 %. Neither
enrichment broth nor prolonged incubation up to 48 h in-
creased the yield of CPE. This point prevalence survey
shows a low CPE prevalence of 0.39 %. Larger scaled
studies are needed in order to confirm the role of chronic
care settings as secondary CPE reservoirs and to adjust the
infection control and prevention recommendations.
Introduction
Infections due to multidrug-resistant organisms and, more
specifically, carbapenemase-producing Enterobacteriaceae
(CPE), are of growing public health concern worldwide [1].
Prior colonization has been shown to increase the risk of sub-
sequent infection due to these multidrug-resistant organisms
[2]. Over the last several years, it became clear that multidrug-
resistant organisms, including CPE, are not only present in
acute care hospitals, but also in long-term care facilities [3].
Moreover, at a national level, the spread and local establish-
ment of CPE are not merely travel-associated [4]. Indeed, in
2013, the mean Belgian CPE incidence was 3.9/105 inhabi-
tants, with a range of 0.0 to 9.3/105 inhabitants when
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incidence was calculated for the different Belgian prov-
inces. More than 50 % of the CPE cases (2012–2013)
had recently been hospitalized in Belgium, and 5 % of
the CPE carriers recently stayed in a Belgian nursing home
(National Reference Center of Multiresistant Gram-
negative Enterobacteriaceae and the National Institute of
Public Health, http://www.nsih.be). Also, 79.6 % of the
890 CPE reported in 2012–2013 to the National
Reference Center were of the OXA-48 type (http://www.
nsih.be). Therefore, there is an urgent need to explore the
possible existence of CPE reservoirs in different healthcare
sectors, including the community and the chronic care
sector.
This point prevalence survey had two main goals. The
first aim was to evaluate the hypothesis of the establish-
ment of a CPE reservoir in residents or patients living in
nursing homes and rehabilitation centers. Secondly, we
compared the analytical performances of different culture
methods (chromogenic selective agars, enrichment broth,
media with antibiotic disks) and a recently commercialized
multiplex real-time polymerase chain reaction (PCR) assay
(Check-Direct CPE) to detect CPE.
Materials and methods
Three nursing homes and one rehabilitation center were in-
cluded in this point prevalence survey. Two nursing homes
(De Plataan, n=80, Sint-Niklaas and Populierenhof, n=80,
Nieuwkerken) were located in the province East Flanders.
The third nursing home (Ter Vlierbeke, n=90, Kessel-Lo)
and the rehabilitation center (National Multiple Sclerosis Cen-
ter, n=134,Melsbroek) included in this survey were located in
Flemish Brabant. Included persons represented a heteroge-
neous group of residents with chronic care needs and different
levels of dependency, as estimated by the Katz scores.
The respective board of managers and Ethical Committees
of University Hospitals Leuven and the National Multiple
Sclerosis Center of Melsbroek approved the study protocol,
with National Number B322201214429.
Screening protocol
Before the start of the study, nurses were given an introduction
lecture with the study background, and practical instructions
for collection of the screening swabs were addressed. Advice
was given that a properly taken rectal swab should be
visibly stained with fecal material. In case of a rectal/
anal anastomosis/injury, the possibility was given to take
peri-anal swabs (with emphasis of visible stools on the swab)
or feces. Residents with a diverting stoma could be sampled
via the fecal collection bag.
Between July 2013 and January 2014, 261 residents/
patients from the three nursing homes and the rehabilitation
center were included. Informed consent was not given by 123
residents/patients, mainly due to their poor cognitive condi-
tion hampering the signature of an informed consent or to their
reluctance against a rectal swab.
From each resident who had given written informed con-
sent (directly or via his/her legal representative), a rectal swab
(ESwab, Copan, Brescia, Italy) was taken after the morning
care. Samples were transported to the microbiology laboratory
of University Hospitals Leuven. Within a maximum of 7 h
after harvesting the ESwab, 100 μL of vortexed liquid Amies
medium was inoculated onto each of the following media:
chromID® CARBA (bioMérieux, Marcy l’Etoile, France),
chromID® OXA-48 (bioMérieux), and MacConkey agar with
a disk of temocillin (30 μg) and meropenem (10 μg) (Rosco
Diagnostica, Neo-Sensitabs, Taastrup, Denmark). Temocillin
was chosen since OXA-48 producers are known to display a
high level of temocillin resistance [5]. Also, 100 μL of
vortexed liquid Amies medium was inoculated into 2.9 mL
of an enrichment broth (tryptic soy broth with 0.25 μg of
ertapenem/mL). After incubation of this broth for 4 h at 35+/
−2 °C in ambient air, 100 μLwas inoculated ontoMacConkey
agar with a disk of temocillin and meropenem.
All agar media were incubated in ambient air at 35+/−2 °C
for 24 h, with a second reading after 48 h of incubation. Any
colony growing on the (chromogenic) agars or within restrict-
ed diameters of the antibiotic disks (<20 mm diameter for
temocillin [6] and <23 mm for meropenem [7]) was identified
by matrix-assisted laser desorption/ionization time-of-flight
mass spectrometry (MALDI-TOF MS Bruker Biotyper,
Bruker Daltonics, Leipzig, Germany). Although the commer-
cial inserts of the chromogenic agars recommend a general
incubation time of 18 to 24 h, we wanted to evaluate whether
the sensitivity would increase after 48 h of incubation. There-
fore, the isolates’ color and the growth on chromogenic agars
was registered both after 24 and 48 h.
Susceptibility testing and molecular confirmation
Antimicrobial susceptibility of the Enterobacteriaceae isolates
recovered from the different culture media was evaluated
by the Vitek® 2 system (AST-N205 card, bioMérieux).
The following antimicrobials were tested: beta-lactams
(ampicillin, amoxicillin–clavulanate, piperacillin–tazobac-
tam, temocillin, cefoxitin, cefuroxime, cefotaxime, ceftazi-
dime, cefepime, meropenem), quinolones (levofloxacin),
nitrofurantoin, aminoglycosides (gentamicin, tobramycin,
amikacin), co-trimoxazole, tigecycline, and colistin. Interpreta-
tion of susceptibility patterns was performed according to Clin-
ical and Laboratory Standards Institute (CLSI) criteria [7] for
all antibiotics except temocillin, for which British Society for
Antimicrobial Chemotherapy (BSAC) guidelines were used
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and for tigecycline and colistin, for which European Committee
on Antimicrobial Susceptibility Testing (EUCAST) interpreta-
tive guidelines were used [6, 8]. In case of a meropenemVitek®
2 minimum inhibitory concentration (MIC)≥0.5 μg/mL, both a
meropenem Etest (range of concentrations: 0.002–32 μg/mL,
bioMérieux) and the KPC/metallo-beta-lactamase (MBL)
confirmation test (ref. no. 98006, Rosco Diagnostica) were
performed. A temocillin MIC ≥16 μg/mL on Vitek® 2 was
confirmed by means of a temocillin Etest (range of con-
centrations: 0.064–1024 μg/mL). All Enterobacteriaceae iso-
lated with confirmed meropenem MIC≥0.5 μg/mL and/or
temocillin MIC≥16 μg/mL were stored at −80 °C for final
molecular confirmation with Check-Direct CPE performed
on the strain.
Each ESwab sample was analyzed by Check-Direct CPE
(ref. no. 18-0080, version 1.1, 2012, Check-Points,
Wageningen, The Netherlands), according to the manufac-
turer’s standard protocol [9]. The Check-Direct CPE PCR
assay is a multiplex real-time PCR based on the TaqMan fast
advanced molecular beacon technique with fluorescent DNA
probes labeled with four different fluorophores (FAM, VIC,
Texas Red, or Cy5) for the detection of blaKPC, blaOXA-48,
blaVIM/NDM, and an internal extraction/inhibition control
[9]. Briefly, 200 μL of Amies medium from the ESwab
was extracted with the specific B protocol on a NucliSENS
easyMag® (bioMérieux) instrument. Extractions were per-
formed within 24 h of rectal sampling. Extracts were frozen
at −20 °C until the PCR was performed in batches. In each
batch of PCR reactions, we used as controls the following:
the kit controls, Escherichia coli ATCC 25293 (negative
control) and characterized positive control CPE strains [an
OXA-48-producing Klebsiella pneumoniae (08119-PEP 136)
and an NDM-producing E. coli (10158-CP 27) National Ref-
erence Center for Multidrug-resistant Enterobacteriaceae,
UCL Mont-Godinne].
Statistical analysis
Sensitivity and specificity with 95 % confidence intervals were
calculated for all culture methods and for Check-Direct CPE
(http://www.cct.cuhk.edu.hk/stat/confidence%20interval/
Diagnostic%20Statistic.htm). Results from Check-Direct CPE
performed on Enterobacteriaceae with meropenem MIC≥0.
5 μg/mL and/or temocillin MIC≥16 μg/mL growing on one
or several of the culture media were regarded as the gold stan-
dard. True-positive samples for carbapenemase production
were considered to be samples yielding presumptive colonies
as described above on any of the culture methods that were
confirmed by Check-Direct CPE PCR on isolated colonies
and ESwab medium. True-negative samples were considered
as absence of growth of Enterobacteriaceae on all culture
methods and a negative Check-Direct CPE PCR on ESwab
medium. False-positive samples by culture were considered
to be Enterobacteriaceae isolates grown on any of the inoculat-
ed agars that were CPE-negative by confirmatory antimicrobial
confirmation tests and Check-Direct CPE on ESwab medium.
False-positive samples by Check-Direct CPE were considered
to be those where only Check-Direct CPE PCR was positive
without growth of CPE on either of the culture methods. A
false-negative sample for a specific culture method occurred
when a molecular confirmed CPE was missed on the specific
culture method but was isolated from at least one other culture
method. False-negative samples by Check-Direct CPE were
those samples with a negative Check-Direct CPE PCR directly
on ESwab medium but with a molecular confirmed CPE on a
grown isolate.
Results
Screening protocol
In total, 261 of the 384 residents/patients were included from
the three different nursing homes and the one rehabilitation
center (De Plataan, n=57/80; Populierenhof, n=53/80; Ter
Vlierbeke, n=69/90; National Multiple Sclerosis Center,
n=82/134).
The level of dependency of the residents was highest in De
Plataan, followed by Ter Vlierbeke and Populierenhof (Katz
scores of class C in 74 %, 51 %, and 32 % of the included
residents, respectively). In the National Multiple Sclerosis
Center, 12 % of the included patients were bed-bound.
Table 1 shows the isolates retrieved from all 261 residents.
It should be noted that, in four samples, there was no growth
on MacConkey agar, suggesting that the swab was not prop-
erly taken.
From the isolated microorganisms on the 257 residual
ESwabs, the number of different Enterobacteriaceae was re-
stricted (n=16). In the first 24 h of incubation, Pseudomonas
spp. were predominant on all agar media except around the
meropenem disk on MacConkey agar (with and without pre-
enrichment step), where Stenotrophomonas spp. predominat-
ed. After 48 h of incubation, the extra yield mainly consisted
of non-fermenters, enterococci, and/or Candida spp. on all
agar media.
Considering the color codes for the strains isolated on
chromID® CARBA, the only E. coli, grown after 24 h of
incubation, was pink, in line with the interpretation guide from
the package insert. The only Enterobacter aerogenes isolate
grewwith white colonies. After 48 h of incubation, two E. coli
strains grew as pink colonies and two Enterobacter spp.
grew as green colonies, conforming to the package insert.
The Klebsiella pneumoniae and Citrobacter freundii strains
grew as white colonies however. For chromID® OXA-48
agar, the only grownK. pneumoniae strain was phenotypically
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bluish-green, after both 24 and 48 h of incubation, as men-
tioned in the package insert.
Susceptibility testing and molecular confirmation
Sixteen different Enterobacteriaceae were isolated. Only one
of the 16 strains had a Vitek meropenem MIC≥0.5 μg/mL
(1 μg/mL). This strain, a K. pneumoniae, had an meropenem
MIC of 0.75μg/mLwith an Etest andwithout evidence for KPC
or MBL, as determined by the KPC/MBL confirmation kit.
This strain harbored an OXA-48 gene, as confirmed with
Check-Direct CPE PCR both on the strain and on the rectal
swab.
Concerning temocillin, eight strains were resistant based on
the Vitek® 2 results (range of MIC values: 16 to≥32 μg/mL).
All eight strains were confirmed to be resistant by the Etest
(MIC≥16 μg/ml), and three of the eight strains had an
MIC≥256 μg/mL. One of these three strains was the OXA-
48-positive K. pneumoniae mentioned above, with temocillin
susceptibilities of≥32μg/mL onVitek® 2 and 512 μg/mLwith
the Etest strip. This isolate also displayed a high resistance
level to piperacillin–tazobactam, consistent with the typical
susceptibility pattern of OXA-48 strains as reported by Huang
et al. [10].
Concerning the Check-Direct CPE, 255 PCRs could be
performed among the 257 ESwabs with growth on
MacConkey (two ESwabs were underfilled to perform
PCR). Of these, there was inhibition in three samples, 250
PCRs were negative, and two PCRs were positive for OXA-
48. The first positive OXA-48 sample was the K. pneumoniae
isolate, with a Ct-value of 29.4 for OXA-48. The second pos-
itive sample had a Ct-value of 33.2 for OXA-48, without
growth of Enterobacteriaceae on either of the culture methods.
This was considered as a false-positive sample. To confirm
this false-positivity, the DNA extract was reanalyzed by the
National Reference Center for multiresistant Gram-negatives
by means of three PCR techniques: Eazyplex (LAMP tech-
nology), Check-Direct CPE, and home-made multiplex PCR.
All results were negative, confirming the false-positivity of
our PCR result.
The single proven case of intestinal carriage of an OXA-
48-producing K. pneumoniae was an 82-year old woman liv-
ing in a nursing home in East Flanders with diabetes mellitus
as the underlying comorbidity and the following as possible
risk factors for CPE: previous colonization with methicillin-
resistant Staphylococcus aureus (MRSA) and CPE, previous
hospitalizations, and antimicrobial use. She was known to be
colonized by this resistant organism since a hospitalization in
June 2012, while the study sample was taken in July 2013. In
September 2013, the resident was still found to be asymptom-
atically colonized by this CPE. Also, she had been hospital-
ized in the 3 months prior to this study, and had received
amoxicillin–clavulanic acid while in hospital. The resident
had no catheter in place, nor had she any dependence in ac-
tivities of daily living (Katz scale A).
Statistical analysis
The sensitivity of the culture methods and Check-Direct
CPE PCR could not be calculated because only one CPE
strain was isolated. The specificity of the culture methods
ranged between 97.7 and 100 % after 24 h of incubation
(Table 2). A limited number of non-CPE grew on chromID®
CARBA (C. freundii, E. coli, K. pneumoniae, E. cloacae, and
E. aerogenes) and onMacConkey agar with temocillin (E. coli
and E. aerogenes) after 48 h of incubation. After 48 h of
incubation, the specificity decreased slightly for the different
culture methods to a range of 97.2–100 % (Table 2). For the
Table 1 Total number of species isolated from 257 ESwabs after 24 and 48 h of incubation
chromID®
CARBA
chromID®
OXA-48
MacConkey,
temocillin
MacConkey,
meropenem
MacConkey temocillin
after ertapenem enrichment
MacConkey meropenem
after ertapenem enrichment
24/48 h 24/48 h 24/48 h 24/48 h 24/48 h 24/48 h
Enterobacteriaceae 2/6 1/1 7/8 0/0 2/4 0/0
Aeromonas spp. 1/1 0/0 1/1 0/0 1/1 0/0
Pseudomonas spp. 81/110 8/18 42/52 0/0 49/54 2/2
Stenotrophomonas spp. 18/20 0/1 0/8 12/16 0/7 15/15
Acinetobacter spp. 1/3 2/12 22/25 0/0 21/25 0/0
Other Gram-negatives 1/2 0/4 0/0 0/0 0/0 0/0
Arcobacter spp. 0/0 1/1 0/0 0/0 0/0 0/0
Enterococcus spp. 1/1 2/11 5/69 0/8 4/50 0/6
Lactobacillus spp. 0/0 0/0 0/2 0/0 0/0 0/0
Staphylococcus spp. 0/0 0/18 0/0 0/0 0/0 0/0
Candida spp. and Geotrichum spp. 1/12 0/11 0/15 0/11 0/1 0/1
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Check-Direct CPE PCR, the specificity was 99.6 %, with one
“false-positive” sample.
Discussion
This study’s aim was to investigate the prevalence of asymp-
tomatic rectal CPE carriage in residents/patients of three Bel-
gian nursing homes and one rehabilitation center, and to eval-
uate different culture methods and a real-time PCR assay
(Check-Direct CPE) to detect CPE.
Only one of the 257 included residents/patients was found
to be a true asymptomatic carrier of CPE. This resident’s rectal
screening culture grew a K. pneumoniae after 24 h on
chromID® OXA-48 and on MacConkey agar with and with
out ertapenem enrichment broth within the defined zone sur-
rounding the temocillin disk. The isolate was missed on
chromID® CARBA but was picked up with the Check-
Direct CPE PCR directly on the ESwab sample. The sample
of the patient with the false-positiveOXA-48 result onCheck-
Direct CPE PCR yielded no growth of Enterobacteriaceae
neither on the chromogenic agars nor on MacConkey agar
(with and without enrichment). Several explanations might
account for the “only molecular” positive result: a higher sen-
sitivity of molecular techniques for the detection of CPE com-
pared to culture, or a true false-positive PCR result, or the
presence of non-expressed OXA-48 in intestinal commensals
of the gut flora, such as Shewanella spp. [11]. Given the neg-
ative confirmatory PCRs, the most likely hypothesis is a true
false-positive PCR result.
Rectal swabs are currently considered to be the most
sensitive site to detect colonization with multidrug-resistant
enteric Gram-negatives [1]. The exact anatomic sampling
site (rectal versus perineal or inguinal) may be of para-
mount importance. The presence of visible fecal staining
on the swab has been proposed as a simple marker for the
quality/amount of material sampled. Likewise, the inocula-
tion of a MacConkey differential agar, which is selective
for the growth of Gram-negatives, can give an indirect
estimation of the quality of the collected rectal swab.
In the present study, the addition of broth enrichment with
subsequent inoculation of solid agar [as per Centers for Dis-
ease Control and Prevention (CDC) recommendations] did
not enhance the detection rate of CPE but was associated with
an increased rate of non-fermenters, which could (in theory)
impede the recovery of CPE by culture overgrowth. Accord-
ingly, this study could not demonstrate the usefulness of an
ertapenem enrichment broth to increase the detection of CPE.
Also, an enrichment step is time-consuming and increases the
turnaround time of the analysis. Likewise, prolonged incuba-
tion of (chromogenic) agars up to 48 h did not increase the
detection rate of CPE but, instead, showed overgrowth by
non-fermenters, enterococci, staphylococci, and/or yeasts.
Table 2 Specificity of culture methods and polymerase chain reaction (PCR) for carbapenemase-producing Enterobacteriaceae (CPE) detection after
24 h and 48 h of incubation
chromID
CARBA
(no. of samples)
chromID
OXA-48
(no. of samples)
MacConkey,
temocillin
(no. of samples)
MacConkey,
meropenem
(no. of samples)
MacConkey
temocillin after
ertapenem
enrichment
(no. of samples)
MacConkey
meropenem
after ertapenem
enrichment
(no. of samples)
Check-Direct
CPE PCR
(no. of samples)
24 h of incubation
True-positive 0 1 1 0 1 0 1
False-positive 2 0 6 0 1 0 1
True-negative 254 256 250 256 255 256 250
False-negative 1 0 0 1 0 1 0
Total 257 257 257 257 257 257 252
Specificity %
(95 % CI)
99.2 (98.1–100) 100 (100–100) 97.7 (95.8–100) 100 (100–100) 99.6 (98.8–100) 100 (100–100) 99.6 (98.8–100)
48 h of incubation
True-positive 0 1 1 0 1 0 NA
False-positive 5 0 7 0 3 0 NA
True-negative 250 256 249 256 253 256 NA
False-negative 1 0 0 1 0 1 NA
Total 257 257 257 257 257 257 NA
Specificity %
(95 % CI)
98.0 (96.3–99.7) 100 (100–100) 97.2 (95.3–99.3) 100 (100–100) 98.8 (97.5–100) 100 (100–100) NA
NA not applicable
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The color codes mentioned in the commercial insert of
chromID® CARBA were not always concordant. The use of
MALDI-TOF as a fast identification technique is an easy
method to rapidly confirm the species identity of colonies
isolated from the different screening agars. Species identifica-
tion of every isolate grown on chromogenic agars before
performing antimicrobial susceptibility testing can save costs
and helps to prevent erroneous antimicrobial susceptibility
data.
In general, all the evaluated culture methods and also
Check-Direct CPE PCR performed well, with specificities
above 97 %.
Overall, the CPE prevalence found in this survey was
0.39 % (1/257 residents). Remark that the only CPE-positive
resident lives in a nursing home in a province where OXA-48 is
more prevalent (8.0/105 inhabitants) (http://www.nsih.be). In
comparison, the current estimated CPE prevalence in Belgian
hospitals is 0.28 % (range 0.13–0.44 %) [10]. Moreover, none
of the 1,526 patients hospitalized on geriatric wards in
University Hospitals Leuven who were screened at admission
by rectal ESwab between February 2013 and February 2014
were found to be colonized with CPE.
This point prevalence study had some limitations. First, we
sampled 261 residents/patients from four institutions, which is
hardly representative for a regional CPE prevalence. Also, 123
(32 %) of the 261 residents did not give informed consent for
the study. This dropout was random though, and not specifi-
cally related to a higher level of care need and, accordingly,
not the cause of a bias in the included study population. Tak-
ing the estimated low CPE prevalence in Belgium into ac-
count, a larger sample size is required to obtain a statistically
meaningful CPE prevalence in a chronic care population. It is
possible that, because of the current low CPE prevalence in
the Belgian population, the constitution of secondary reser-
voirs in long-term care facilities and nursing homes cannot
yet be demonstrated. Likewise, for MRSA, this phenomenon
of spread from acute care to chronic care institutions has taken
a decade [12]. Also, the optimal method to screen for CPE
carriage is still not known. Rectal swabs have been mentioned
as the most sensitive sample type [3], but the pre-analytical
phase of specimen collection may, likewise, be of critical
importance for a high sensitivity. As such, a small number
of MacConkey agars did not show growth, pointing to
suboptimal sampling sites (perineum instead of rectum).
Finally, Check-Direct CPE is a commercial assay validated
for a restricted number of CPE genes. Although it might be
possible that we missed new carbapenemases not present in
this molecular assay, we are quite confident that such new
carbapenemase genes were not present in this series based
on the phenotypic resistance patterns of the Enterobacteri-
aceae isolated and on the national CPE data collected by
the National Reference Center both before and after this
survey period.
Conclusion
In conclusion, we only found one asymptomatic carrier of
carbapenemase-producing Enterobacteriaceae (CPE) (OXA-48)
in this point prevalence survey performed in three nursing homes
and one rehabilitation center (n=257). The specificity of the
different culture methods and of Check-Direct CPE polymerase
chain reaction (PCR) was at least 97 %. In this study’s regions,
where OXA-48 is a problem, the use of chromogenic biplates
such as chromID® CARBA SMART (bioMérieux),combining
chromID® CARBA and chromID® OXA-48 to recover
both OXA-48, KPC, and NDM is worthy of consideration.
Neither enrichment broths nor prolonged incubation up to
48 h increased the yield of CPE. This preliminary survey
could not confirm the presence of a CPE reservoir in nurs-
ing homes or chronic care settings in Belgium in the period
2013–2014. Additional larger scale surveys are needed to
assess the role of chronic care settings as possible secondary
CPE reservoirs and to adjust the infection control and pre-
vention recommendations. Until these studies are performed,
chronic care institutions need to focus on standard infection
control measures and restriction of antimicrobial use.
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